Overview

The Effects Diflunisal on the Levels of BMS-986165 in Healthy Participants

Status:
Completed
Trial end date:
2019-11-25
Target enrollment:
Participant gender:
Summary
BMS-986165 Is broken down by the body through multiple pathways. This study Investigates the effect of blocking one pathway in the drug levels of BMS-986165 in health subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
BMS-986165
Diflunisal